AMPICILLIN AND SULBACTAM Drug Patent Profile
✉ Email this page to a colleague
When do Ampicillin And Sulbactam patents expire, and when can generic versions of Ampicillin And Sulbactam launch?
Ampicillin And Sulbactam is a drug marketed by Acs Dobfar, Antibiotice, Astral, Eugia Pharma Speclts, Hikma, Hospira Inc, Hq Speclt Pharma, Istituto Bio Ita Spa, Pharm Assoc, Sandoz, and Steriscience. and is included in twenty-three NDAs.
The generic ingredient in AMPICILLIN AND SULBACTAM is ampicillin sodium; sulbactam sodium. There are seventy drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the ampicillin sodium; sulbactam sodium profile page.
Summary for AMPICILLIN AND SULBACTAM
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 23 |
Finished Product Suppliers / Packagers: | 12 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Clinical Trials: | 17 |
Patent Applications: | 269 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AMPICILLIN AND SULBACTAM at DailyMed |
Recent Clinical Trials for AMPICILLIN AND SULBACTAM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Konya Training and Research Hospital | Phase 4 |
Konya Meram State Hospital | Phase 4 |
Assiut University | Phase 4 |
Pharmacology for AMPICILLIN AND SULBACTAM
Drug Class | Penicillin-class Antibacterial beta Lactamase Inhibitor |
Mechanism of Action | beta Lactamase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for AMPICILLIN AND SULBACTAM
US Patents and Regulatory Information for AMPICILLIN AND SULBACTAM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | AMPICILLIN AND SULBACTAM | ampicillin sodium; sulbactam sodium | INJECTABLE;INJECTION | 065241-002 | Jul 25, 2006 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pharm Assoc | AMPICILLIN AND SULBACTAM | ampicillin sodium; sulbactam sodium | INJECTABLE;INJECTION | 065316-001 | Jun 29, 2007 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sandoz | AMPICILLIN AND SULBACTAM | ampicillin sodium; sulbactam sodium | INJECTABLE;INJECTION | 065310-002 | Jul 25, 2006 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |